Yao, M S <br/><br/>
The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jun 1997 
 - 469-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(97)00010-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Brain Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cranial Fossa, Posterior<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Neoplasm Staging<br/>Neuroectodermal Tumors, Primitive--drug therapy<br/>Time Factors<br/>Treatment Failure